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ABSTRACT
Fracture healing is a complex physiological process. Multiple factors regulate this cascade of molecular 
reactions, affecting different sites in the osteoblast lineage, through various processes such as: migration, 
proliferation, chemotaxis, differentiation, inhibition, and extracellular protein synthesis. The omentum is a 
serous membrane made up of a lattice of blood vessels and fat. Basically, it is a highly vasculated organ with a 
rich source of angiogenic factors that promote the growth of blood vessels into whatever tissue it is placed close 
to. Recent studies have revealed that the omentum, apart from being a great source of various growth factors, 
also contains omnipotent stem cells that can differentiate into a variety of cell types. The study was carried 
out on 16 adult male New Zealand rabbits in the same condition. A large segmental defect was created in the 
radius of each animal in groups A and B. In group B the defect was fi lled with a piece omental fat tissue. The 
animals were euthanized 56 days after the operation and the bones removed for histomorphometric analysis. 
Histomorphometric analysis was performed. The osteoblast interface (Ob.S/BS) proved to be the statistically 
signifi cant parameter (P = 0.005). An osteoblast interface was found in the treated group in contrast to the 
control. The surface of trabecula covered with the osteiod and osteoblast interface showed a high degree of 
positive linear correlation, in both the control and the treated group. Our study shows that the statistically 
signifi cant osteoblast interface leads to the conclusion that omental fat tissue has a certain infl uence on bone 
turnover, especially on the formation of the newly-created bone. 
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Introduction
Adipose tissue is considered to be the largest endocrine gland, because it produces 
free fatty acids, hormones, growth factors, and cytokines, such as leptin, adiponectin, 
resistin, VEGF, HGF, IGF-1, angiogenin, IL-6, TNF-α, and angiopoietins. (NEELS 
et al., 2004; RUPNICK, 2002). Growing adipose tissue contains a diversity of cell types 
including adipocytes, adipose stromal cells (ASCs), endothelial cells, and infl ammatory 
cells (REHMAN et al., 2004). The diversity of heterogeneous cell populations determines 
the expression of multiple growth factors and cytokines, that either individually or jointly 
regulate vessel growth, although little is known about the functional interplay between 
these factors (CAO, 2005).
Adipocytes develop from mesenchymal cells via a complex cascade of transcriptional 
and non-transcriptional events. Adipocyte differentiation is a complex process 
accompanied by coordinated changes in cell morphology, hormone sensitivity and gene 
expression, that have been studied primarily in murine preadipocyte cell lines. In the 
literature, adipose-derived stromal cells have been termed ‘‘pre-adipocytes” and there 
is a growing appreciation that they are multipotent, with chondrogenic, neurogenic 
and osteogenic capabilities.(ZUK et al., 2002). ASCs secrete high levels of a number of 
angiogenic factors (BOULOUMIE et al., 2001). ASCs (adipose stromal cells) represent a 
major area of interest for research and have a potential role as building blocks for clinical 
cell therapy. Growth factors are also a key interest in regenerative medicine. The BMPs 
are part of the transforming growth factor beta (TGF- β) superfamily, and have been 
shown to take part in bone and cartilage formation, fracture healing and repair of other 
musculoskeletal tissues. (MATTHEWS, 2005). The osteoinductive growth factors rhBMP-2 
and -7 are in clinical use. They induce ossifi cation by recruiting mesenchymal cells from 
surrounding tissues and differentiating these cells towards osteoblasts. (SAMARTZIS et 
al., 2005).
The TGF- β family contains three closely related mammalian isoforms:TGF β 1, β 2, 
and β 3, that arose by duplication of a common ancestor. TGF- β 1 regulates a broad range 
of biological processes, including cell proliferation, cell survival, cell differentiation, 
cell migration, and production of extracellular matrix (ECM). The combined actions 
of these cellular responses mediate the global effects of TGF-β1 on immune responses, 
angiogenesis, wound healing, development, and bone formation. Bone formation by 
TGF-β1 is promoted through chemotactic attraction of osteoblasts, enhancement of 
osteoblast proliferation and the early stages of differentiation, with production of ECM 
proteins, stimulation of type II collagen expression and proteoglycan synthesis by 
chondrocyte precursor cells (PEPPER, 1997; LETTERIO and ROBERTS, 1998). 
This study aims to investigate the use of omental fat tissue in order to improve new 
bone formation in nonunion defect of rabbit radius fi lled with autologous omental graft.
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Materials and methods
The research was conducted on samples of the omentum of fi ve rabbits, which were 
previously euthanized with introcardiac injections 0.3 ml/kg per weight of the preparation 
T61 (Hoechst, Munich, Germany). The euthanasia was conducted according to the Law 
and with observance of regulations on the ethics of animal welfare standards of the 
Republic of Croatia and the European document on keeping and handling laboratory 
animals: “Directive for the Protection of Vertebrate animals used for Experimental and 
other Purposes” (86/609/EEC). For immunofl uorescence determination of TGF-1 
molecules in the omentum, we used omentum samples of 1 cm3 size and fi xed them in 
10% formaldehyde, buffered in phosphate puff (pH 7.2) The rabbit omentum samples, 
fi xed in 10% buffered formaldehyde, were dehydrated by immersion in 70 % ethanol (for 
2 days), 96% ethanol (for one hour) and 100% ethanol (twice per hour). The processed 
omentum tissue was immersed for one hour in the mixture of chloroform and pharaplast 
(1:1) at a temperature of 56 degrees, and then fi tted in pharaplast. After cooling, the 
blocks were cut with microtom (Reichert-Jung, Germany) into parts 6-7m thick.. The 
deparafying of cuts was carried out by dipping in two changes of xylol (for ten minutes), 
in declining concentrations of ethanol (100%, 96%, 80%, 70%; all for fi ve minutes) and 
two changes of distilled water (for fi ve minutes). 
The sample processing. The omentum samples of rabbits fi xed in 10% buffered 
formaldehyde were dehydrated by immersion in increasing concentrations of alcohol and 
were fi tted in pharaplast according to the procedure previously described. The blocks were 
cut with microtom.. The treated cuts were subjected to the indirect immunofl uorescence 
method. The cuts were incubated with primary antibody for two hours at room 
temperature. We used the mouse monoclonal antibody TGF-1 (Mouse monoclonal anti- 
TGF-1 antibody, R&D Systems) diluted in 1:5 PBS. After fl ushing in PBS puff (three 
times for fi ve minutes), the cuts were incubated with a secondary antibody. We used 
goat against mouse antibody, conjugated with fl uorescein (Goat F(ab’)2 Anti-Mouse Ig’s, 
Fluorescein Conjugate) diluted in 1:10 PBS. The cuts were fl ushed in PBS (three times 
for fi ve minutes) and in distilled water (for fi ve minutes). After immunofl uorescence, the 
tissue cuts were dehydrated in a series of increasing concentrations of ethanol, cleared 
with immersion in xylol and kept in a freezer for two days. The samples obtained were 
processed with the help of fl uorescentic microscope Olympus BX 51 under magnifi cation 
of 400. By observing the samples with the assistance of the fl uorescentric microscope, the 
fl uorescence was determined which was clearly confi rmed by the test results of TGF-1 of 
the rabbit omentum (Fig. 1). The sample analysis was conducted at the “Ruđer Bošković” 
Institute.
Animal procedure. Sixteen male New Zealand rabbits, 2.50 ± 0.30 kg, were kept in 
the same living conditions (room temperature 20 ± 1 °C, relative humidity 55 ± 5%). They 
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were fed the standard diet and administrated water ad libitum. The animals were denied 
food for 12 h preoperatively, but had access to water. The animals were anaesthetized by 
injecting 5 mg/kg of xylazine and 40 mg/kg of ketamine intramuscularly. 
The euthanasia was conducted according to the Law and the ethics and standards 
of the animal welfare of the Republic of Croatia and the European document regulating 
the keeping and handling of the laboratory animals: “Directive for the Protection of 
Vertebrate Animals Used for Experimental and other Purposes” (86/609/EEC).
Sixteen rabbits were divided into two groups. A large segmental defect was created 
in the radius of each animal in both A and B groups. In group B the defect was fi lled with 
a piece of omental tissue fat; a small piece of omental fat was obtained from a 3 cm mid-
abdomen incision. 
Ketofen® was administered intramuscularly for 3 days to control pain. On days 2, 
9 and 16 before sacrifi ce, each rabbit was injected intramuscularly with fl uorochromes 
demeclocycline (20 mg/kg), alizarin complexone (30 mg/kg), and calcein (20 mg/kg), 
respectively. All fl uorochromes were purchased from Sigma (Deisenhofen, Germany). 
The animals were euthanized 56 days after operation and the bones removed for 
histomorphometric studies. The bone samples assigned for histomorphometry were 
embedded undecalcifi ed in methylmetacrylate. Sections 5 μm thick were cut with a 2040 
outcut microtome (Reichert-Jung, Heildelberg; Germany) and stained with Toluidine 
blue and Goldner-Mason. The sections were analyzed using an Opton microscope. 
The nomenclature follows the recommendations of the American Society for Bone and 
Mineral Research.
Fig. 1. Immunofl uorescence confi rms the presence of TGF-β1 in the omentum
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Results
Eight weeks afte r the operation, the histological as well as radiological fi ndings 
showed that the greater omentum graft provoked signifi cant bone activity with 
Fig. 2. The specimen without free omental 
graf, no bone turnover rate is observed 
Toluidin blue staining, ×10
Fig. 3. Specimen with free omental graft, 
signifi cant bone activity with predominational 
bone forming present, Toluidin blue, ×10
Fig. 4. By observation of the radiographs 
of the control group, no signs of new callus 
formation could be noticed.
 Fig. 5. By visual observation of radographs it 
is noticable that the bone healing process on 
the large segmental defect was more intensive 
in the treated group after 8 weeks. The greater 
bone callus volumen was observed in the 
treated group
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Fig. 6. Levence test has proved that osteoblast interface (Ob.S/BS) is statistically signifi cant 
parameter (P = 0.005)
Fig. 7. The trabecular surface covered by osteoid and osteoblast interface showed a high degree of 
positive correlation, both in the control r(10)00.701, P = 0,024, marked red on the fi gure and the 
treated group r(7) 0,915, P = 0,004, marked green on the fi gure
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predominatial bone forming, and bone turnover rate with osteoblast domination (Fig. 3, 
5), while in the control group the bone activity was low and no bone turnover rate was 
observed. (Fig. 2, 4).
The Levence test for equal variance showed that in the case of osteoblast interface 
(Ob.S/BS) the samples had equal variance. Therefore, analysis was performed on 
these samples (Analysis of Variance, ANOVA).The osteoblast interface proved to be a 
statistically signifi cant parameter (P = 0.005). The osteoblast interface was found in the 
treated group in contrast to the control one. The surface of the trabecula covered with 
osteiod and osteoblast interface showed a high degree of positive linear correlation in 
both the control and the treated group.
Discussion
Repair of bone defects caused by severe trauma, resection of tumors, and congenital 
deformities remains a major challenge to surgeons. As a gold standard for the treatment 
of bone defects in clinically treated patients, autologous bone grafts are usually limited by 
considerable donor site mobility and the available supply of tissue that can be harvested 
(BURCHARDT, 1983; YOUNGER and CHAPMAN, 1989). Bone marrow stromal cells 
(BMSCs) are the commonly used seed cells for bone engineering (BRUDER et al., 1998). 
Recent reports indicate adipose tissue as a novel source of multipotent stem cells, which 
can be used in pharmacological studies and clinical praxis. Growing adipocytes produce 
a dozen angiogenic factors, including leptin, VEGF, FGF-2, HGF, IGF, TNF-α, TGF-β, 
placental growth factor (PlGF), VEGF-C, resistin, tissue factor (TF), neuropeptide Y 
(NPY), heparin-binding epidermal growth factor, and angiopoietins (VOROS et al., 2005).
Osteoblasts originate from common progenitors, which are capable of differentiating 
into other mesenchymal cell lineages, such as chondrocytes, myoblasts, and bone marrow 
stromal cells including adipocytes. During the differentiation process from mesenchymal 
progenitors, various hormones and cytokines regulate osteoblast differentiation. Cbfa1 
plays important roles in skeletal development at two stages, for commitment to skeletal 
lineage cells and for maturation of osteoblasts in postnatal development (YAMAGUCHI 
et al., 2000).
The formation, deposition, and mineralization of bone tissue are executed by the 
osteoblasts that differentiate from mesenchymal precursor cells. The key transcription 
factor that drives the mesenchymal precursor cell toward the osteoblast lineage and 
controls bone formation is Runx2 (Cbfa1), and it regulates the expression of all known 
marker genes expressed by the osteoblast (DUCY et al., 1997). Runx2 binding sites are 
found in the promoters of several bone formation markers, including collagen 1, ALP, 
osteopontin, RANKL, and osteocalcin (STEIN et al., 2004).
196 Vet. arhiv 83 (2), 189-199, 2013
O. Smolec et al.: The infl uence of transforming growth factor beta-1 proven in autologous omental graft on 
the healing of critical size defects in rabbit radius
TGF- β1 is covered up in a latent form by bone cells and is stored in the ECM. Active, 
resorbing osteoclasts are capable of activating TGF-β1, which in turn attenuates further 
bone resorption by impairing osteoclastogenesis and promotes bone formation through 
chemotactic attraction and stimulation of proliferation and differentiation of osteoblast 
precursors. The in vitro effects of TGF-β1 on cells of the osteoblast and osteoclast 
lineage depend greatly on factors such as cell differentiation stage, cell density, TGF-β1 
concentration, the presence of serum, and other culture conditions. TGF-β1 increases 
bone formation in vitro mainly by recruiting osteoblast progenitors and stimulating
their proliferation, thus expanding the pool of committed osteoblasts, as well as by 
promoting the early stages of differentiation (ALLISTON et al., 2001; MAEDA et al., 2004).
Induction of osteoblast-specifi c gene expression in these cells requires coordinated 
action between Runx2 and BMP2-induced Smad5 (LEE et al., 2000). In the early 
differentiation stage, TGF- β1 induces the expression of Runx2 in combination with 
BMPs. Despite these positive reports, the osteoinductive capacity of TGF- β1 is rather 
weak when compared with that of the BMPs. As yet, no clinical application has been 
developed for TGF- β1, whereas BMP-2 and BMP-7 have already been used in clinical 
trials and have proven their effi cacy in the healing of critical-sized fi bular defects and tibial 
nonunions in humans (GEESINK et al., 1999; FRIEDLAENDER et al., 2001). In an in vivo 
experimental model of fracture healing, BMP-2 induced differentiation of mesenchymal 
cells into osteoblasts and chondrocytes during intramembranous bone formation and 
early chondrogenesis, whereas TGF-β1 expression correlated with active differentiated 
osteoblasts and chondrocytes during chondrogenesis and endochondral ossifi cation (SI 
et al., 1997).
In bone, TGF- β1 plays an important role in keeping the balance between the two 
tightly regulated processes of bone resorption and subsequent bone formation (MUNDY, 
1991).
TGF-β also has many other roles, including promoting angiogenesis (BOLANDER, 
1992), differentiation of periosteal mesenchymal cells into chondroblasts and osteoblasts 
(JOYCE et al., 1990; SANDBERG et al., 1993) regulating cartilage matrix calcifi cation; 
and stimulating osteoblast activity and intraosseus wound regeneration (MUNDY, 1993; 
TALLEY et al.,1995). According to our investigation the results showed a signifi cant 
difference between the treated group and the control group in relation to the parameters 
of bone turnover and mineralization, as manifest in the presence of the statistically 
signifi cant activity of osteoblasts on the bone defect. Moreover, the results showed the 
absence of dissociation between osteoblast and osteoclast activity, which means that 
normal balance between deconstruction and new bone formation was sustained, whereas 
the increased osteoblast activity was noticeable only on the bone defect (SMOLEC et al., 
2010).In conclusion these results indicate that omental fat tissue transplant application 
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stimulates bone healing, which opens the possibility of wide clinical application of the 
omental fat tissue in reconstructive surgery.
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SAŽETAK
Cijeljenje loma kosti složeni je fi ziološki proces. Više faktora regulira ovu kaskadu molekularnih reakcija 
utječući na osteoblaste kroz razne procese kao što su migracija, proliferacija, kemotaksija, diferencijacija, 
inhibicija i ekstracelularna sinteza proteina. Omentum je serozna membrana koju čini mreža krvnih žila i 
masnog tkiva. To je izrazito vaskulariziran organ koji je ujedno bogat izvor angiogenih faktora koji potiču rast 
krvnih žila u bilo kojem tkivu na koje ga se položi. Nedavna istraživanja su otkrila, da omentum osim što je 
obilan izvor različitih faktora rasta, također sadrži omnipotentne matične stanice koje se mogu diferencirati u 
razne tipove stanica. Istraživanje je obavljeno na 16 odraslih mužjaka novozelandskog kunića istog statusa. 
Na radijusu svake životinje, podijeljene u skupine A i B, učinjen je veliki segmentalni defekt. U skupini B 
defekt je bio ispunjen komadićem (isječkom) masnog tkiva omentuma. Životinje su bile eutanazirane 56. 
dana nakon operativnog zahvata, a kosti su zatim izuzete za potrebe histomorfometrijske analize. Učinjena 
je histomorfometrijska analiza. Sloj osteoblasta (Ob.S/BS) pokazao se kao statistički značajan pokazatelj (P 
= 0,005). Sloj osteoblasta ustanovljen je u pokusnoj skupini u usporedbi s kontrolnom skupinom. Površina 
trabekula pokrivena osteoidima i slojem osteoblasta pokazala je visok stupanj pozitivne linearne korelacije i u 
kontrolnoj i pokusnoj skupini. Naše istraživanje pokazuje da sloj osteoblasta statistički značajno povećan, te se 
može zaključiti da masno tkivo omentuma ima stanoviti utjecaj na obnavljanje kostiju, naročito na formiranje 
novostvorene kosti.
Ključne riječi: kunić, omentum, masno tkivo, kost, cijeljenje________________________________________________________________________________________
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